Cargando…
Pediatric Drug Nitazoxanide: A Potential Choice for Control of Zika
Zika virus (ZIKV) infection can be the cause of congenital malformations, including microcephaly in infants and can cause other disorders such as Guillain-Barré syndrome, meningoencephalitis, and myelitis, which can also occur in some infected adults. However, at this time, there is no drug approved...
Autores principales: | Cao, Rui-Yuan, Xu, Yong-fen, Zhang, Tian-Hong, Yang, Jing-Jing, Yuan, Ye, Hao, Pei, Shi, Yi, Zhong, Jin, Zhong, Wu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414027/ https://www.ncbi.nlm.nih.gov/pubmed/28480282 http://dx.doi.org/10.1093/ofid/ofx009 |
Ejemplares similares
-
A Pilot Clinical Trial of Nitazoxanide in the Treatment of Chronic Hepatitis B
por: Rossignol, Jean‐François, et al.
Publicado: (2019) -
Adenosine Analog NITD008 Is a Potent Inhibitor of Zika Virus
por: Deng, Yong-Qiang, et al.
Publicado: (2016) -
Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis
por: Li, Chang-hong, et al.
Publicado: (2021) -
Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19?
por: Mahmoud, Dina B., et al.
Publicado: (2020) -
Zika Virus Replicons for Drug Discovery
por: Xie, Xuping, et al.
Publicado: (2016)